Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review

Annals of Oncology

Volumn 25, Issue 10, 2014, Pages 1914-1918

  Versteeg, K S ^a   Konings, I R ^a   Lagaay, A M ^b   van de Loosdrecht, A A ^a   Verheul, H M W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

Author keywords

cancer; decision making; elderly; geriatric assessment; geriatric oncology

Indexed keywords

AGED; AGING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GERIATRIC ASSESSMENT; HUMAN; NEOPLASMS; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

AGED; AGING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GERIATRIC ASSESSMENT; HUMANS; NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 84903294878     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu052     Document Type: Review

References (32)

1. Aapro, M.S., Köhne, C.H., Cohen, H.J., et al. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 10 (2005), 198–204.
2. Jemal, A., Siegel, R., Ward, E., et al. Cancer statistics 2009. CA Cancer J Clin 4 (2009), 225–249.
3. Kennedy, B., Cancer death and older age. Cancer 6 (1998), 1066–1068.
4. Zullman, D.B., Sussman, J., Chen, X., et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26:7 (2011), 1606–1629.
5. Vulto, A., Louwman, M., Rodrigus, P., et al. Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002. Radiother Oncol 78 (2006), 131–137.
6. Aapro, M.S., About geriatric oncology. Eur J Cancer 43 (2007), 2141–2143.
7. Satariano, W.A., Ragland, D.R., The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120 (1994), 104–110.
8. Balducci, L., Beghe, C., Pharmacology of chemotherapy in the older cancer patient. Cancer Control 6 (1996), 466–470.
9. Extermann, M., Muss, H., Conducting clinical trials for patients who are frail or elderly. Am Soc Clin Oncol 45 (2009), 289–293.
10. Solomon, D., Brown, A.S., Brummel-Smith, K., et al. National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision making. J Am Geriatr Soc 36:4 (1988), 342–347.
11. Terret, C., Albrand, G., Moncenix, G., et al. Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question. Crit Rev Oncol Hematol 77 (2011), 142–147.
12. Tucci, A., Ferrari, S., Botelli, C., et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large who benefit from aggressive therapy. Cancer 19 (2009), 4547–4553.
13. Maas, H.A., Janssen-Heijnen, M.L., Olde Rikkert, M.G., et al. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 43 (2007), 2161–2169.
14. Repetto, L., Fratino, L., Audisio, R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20 (2002), 494–502.
15. C Kenis H Wildiers U Wedding. Practice guideline: comprehensive geriatric assessment (CGA) in oncological patients. Available at: http://www.siog.org/images/SIOG_documents/cga_practice:guideline_wildiers_jul2011.pdf. (4 March 2014, date last accessed).
16. Extermann, M., Aapro, M., Bernabei, R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55 (2005), 241–252.
17. Massa, E., Madeddu, C., Cipulli, G., et al. An attempt to correlate a “Multidimensional Geriatric Assessment” (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study. Crit Rev Oncol Hematol 1 (2008), 75–83.
18. Marinello, R., Marenco, D., Roglia, D., et al. Predictors of treatment failures during chemotherapy: a prospective study on 110 older cancer patients. Arch Gerontol Geriatr 48 (2009), 222–226.
19. Puts, M.T.E., Monette, J., Girre, V., et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 2 (2011), 138–149.
20. Aaldriks, A., Maartense, E., le Cessie, S., et al. Predictive value of geriatric assessment for patients older than 70 years treated with chemotherapy. Crit Rev Oncol Hematol 2 (2011), 205–212.
21. Hurria, A., Togawa, K., Mohile, S., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 25 (2011), 3457–3465.
22. Extermann, M., Boler, I., Reich, R., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 13 (2012), 3377–3386.
23. Aaldriks, A.A., Giltay, E.J., le Cessie, S., Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy. Breast, 2013 [Epub ahead of print].
24. Soubeyran, P., Fonck, M., Blanc-Bisson, C., et al. Predictors of early death risk in older patients treated with first line chemotherapy for cancer. J Clin Oncol, 15, 2012, 18291834.
25. Girre, V., Falcou, M.C., Gisselbrecht, M., et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?. J Gerontol A Biol Sci Med Sci 7 (2008), 724–730.
26. Caillet, P., Canoui-Poitrine, F., Vouriot, J., et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 27 (2011), 3636–3642.
27. Chaïbi, P., Magné, N., Breton, S., et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 79 (2011), 302–307.
28. Marenco, D., Marinello, R., Berruti, A., et al. Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service. Crit Rev Oncol Hematol 68 (2008), 157–164.
29. Soubeyran, P., Bellera, C.A., Gregoire, F., et al. Validation of a screening test for elderly ptients in oncology. J Clin Oncol, 26(suppl), 2008 abstr. 20568.
30. Kenis, C., Bron, D., Libert, Y., et al. Relevance of a systemic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 5 (2013), 1306–1312.
31. Hamaker, M.E., Vos, A.G., Smorenburg, C.H., et al. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older cancer patients. Oncologist 11 (2012), 1439–1449.
32. Puts, M.T., Hardt, J., Monette, J., et al. Use of geriatric assessments for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 15 (2012), 1133–1163.